2.6.2 Viruses

Overview of Viruses in USMLE Microbiology

Viruses are a core part of USMLE microbiology because they combine key ideas from molecular biology, immunology, and pathology, and they frequently appear as clinical vignettes. At this level you should focus on how viruses are structured, how they replicate, how they spread, and what patterns help you recognize viral diseases and design prevention and treatment strategies.

This chapter introduces common principles that apply across many viral families. The specific details of individual viruses and systemic infections will appear in other chapters. Here the aim is to give you a framework for understanding any virus you encounter.

Basic Structure of Viruses

A virus is an acellular infectious particle. It cannot carry out its own metabolism or replication. Instead it uses host cell machinery to make new viral particles. Every virus has at least a genome and a protein shell, and many have an additional envelope.

The viral genome can be either DNA or RNA. It may be single stranded or double stranded and can be linear or circular. The nature of the genome determines how the virus will make mRNA, which is central to all viral replication.

Surrounding the genome is the capsid, a protein coat that protects the nucleic acid and helps deliver it into host cells. Capsids are typically icosahedral or helical when visible at the structural level. The pattern of capsid symmetry is often used to classify viruses and is frequently mentioned in exam questions.

Some viruses also have a lipid envelope that surrounds the capsid. This envelope comes from host cell membranes and contains viral glycoproteins that act as attachment and entry proteins. Enveloped viruses are usually more fragile outside the host because their lipid membranes are disrupted by drying, detergents, and solvents. Nonenveloped, or naked, viruses have only capsid and genome and are generally more resistant in the environment.

Viral Genomes and the Baltimore Classification

On the USMLE you will often be asked to predict how a virus synthesizes mRNA and replicates its genome. The Baltimore classification organizes viruses into groups based on these strategies. The central idea is that all viruses must produce mRNA that can be translated by host ribosomes.

At the center of the scheme is viral mRNA, usually written as $+ \text{RNA}$. Each class describes how the virus reaches this state. You do not need to memorize every family from the Baltimore classes at this stage, but you should know the basic logic.

A simple way to connect genome type to replication strategy is summarized below.

Positive sense RNA acts like mRNA and can be translated as soon as it enters the cytoplasm. Negative sense RNA is complementary to mRNA and must be converted to a positive strand before translation. This conversion requires a viral RNA dependent RNA polymerase that must be supplied by the virus.

Enveloped Versus Nonenveloped Viruses

The presence or absence of an envelope has strong implications for transmission, environmental stability, and disinfection. Questions often test this indirectly by describing where transmission occurs or how the virus is inactivated.

Enveloped viruses, with their host derived lipid membranes, are sensitive to heat, drying, and detergents. They usually require close contact, droplets, blood, or sexual contact for transmission. They are inactivated on surfaces by alcohols and common disinfectants that disrupt lipids.

Nonenveloped viruses are more resistant to environmental stress and can survive passage through the gastrointestinal tract. They are commonly transmitted by the fecal oral route, through contaminated food or water, or via fomites.

A simplified comparison is helpful.

Recognizing that a virus is enveloped or nonenveloped lets you infer much about its behavior, even before memorizing the specific family.

Steps in the Viral Replication Cycle

All viruses follow a general sequence of events in the host cell. The location of each step and the enzymes required differ among virus classes, but the conceptual pattern is similar.

First comes attachment, also called adsorption. Viral surface proteins bind to specific receptors on the host cell. These receptors are often normal host molecules such as proteins or carbohydrates. The specificity of this interaction determines the tropism, or which cell types and species the virus can infect.

After attachment the virus enters the cell. Enveloped viruses usually enter by fusion of their membrane with the host membrane or via receptor mediated endocytosis followed by membrane fusion. Nonenveloped viruses typically enter by endocytosis or direct penetration. Once inside, the viral capsid is removed in a process called uncoating, which releases the genome into the appropriate cellular compartment.

The virus then uses its genome to direct synthesis of viral mRNA and proteins. DNA viruses usually replicate in the nucleus, often using host DNA dependent RNA polymerase to make mRNA. RNA viruses usually replicate in the cytoplasm and must encode their own polymerases to synthesize RNA from RNA.

At the same time the virus replicates its genome. This often occurs using viral enzymes. A few viruses, particularly retroviruses and hepadnaviruses, use reverse transcriptase to make DNA from RNA, which then integrates or persists in the nucleus.

Next, viral proteins and genomes assemble into new virions. Finally, these virions exit the cell. Nonenveloped viruses usually cause cell lysis when they are released. Enveloped viruses often bud from the cell membrane or internal membranes while acquiring their envelope.

High mutation rates in RNA viruses are central to antigenic variation, drug resistance, and the need for updated vaccines.

Cytopathic Effects and Viral Pathogenesis

Viruses cause disease by damaging cells directly, by triggering immune responses, or by transforming cells. On the USMLE, cytopathic effects are often described in laboratory cell cultures or in histologic specimens as clues to the underlying virus.

Direct cytopathic effects include cell rounding, lysis, formation of multinucleated giant cells, and inclusion bodies within the nucleus or cytoplasm. Different viruses form characteristic patterns. While the details belong to systemic or organism specific chapters, it is important to recognize that cytopathic change is the visible effect of viral replication and assembly inside the cell.

Immune mediated damage occurs when the host immune system attacks infected cells. Cytotoxic T lymphocytes recognize viral peptides on MHC class I and kill cells. While this controls infection, it also damages tissues, and many of the symptoms of viral illness are due to this immune response rather than the virus itself.

Some viruses establish latent infection. The viral genome persists in cells with little or no production of infectious particles for prolonged periods. Reactivation can occur during immunosuppression or stress. Latency enables lifelong infection and is a common source of recurrent disease.

A subset of viruses are oncogenic. They promote uncontrolled cell growth by inserting near or within host genes, encoding viral oncogenes, or interfering with tumor suppressor pathways. The association between specific viruses and cancers is a frequent USMLE topic, but the general mechanism is through viral alteration of cell cycle regulation.

Host Range, Tropism, and Transmission

Host range describes which species a virus can infect. Tropism describes which tissues or cell types within a host are susceptible. Both are determined largely by receptor binding and intracellular factors.

For example, a virus that binds a receptor only present on respiratory epithelium will primarily cause respiratory disease and spread by respiratory droplets. A virus that infects gastrointestinal epithelium and resists acid will spread via fecal oral routes. A virus that primarily infects hepatocytes will produce liver disease and be detected by elevated liver enzymes.

Transmission routes strongly influence both public health measures and clinical scenarios. Respiratory viruses present with cough, sore throat, and droplet spread. Enteric viruses present with diarrhea and vomiting and are linked to contaminated water and food. Blood borne viruses are linked to needle sharing, transfusions, and sexual exposure.

Reading a vignette carefully for organ involvement and exposure history allows you to narrow down possible viral agents, even before matching specific laboratory tests.

Antiviral Targets and Mechanisms of Action

Viruses rely on host machinery for many steps, but they encode certain unique enzymes and proteins that can be selectively targeted by antiviral drugs. Knowledge of the general replication cycle helps predict where drugs can act.

Common antiviral targets include viral attachment or entry proteins, viral uncoating, viral polymerases that synthesize DNA or RNA, reverse transcriptase, viral proteases that process polyproteins, and viral neuraminidase or other enzymes required for assembly or release.

Because many viruses share similar enzymes, especially among related families, one drug class can be effective against several viruses that use the same replication step. However, viral polymerases are error prone, which facilitates rapid development of resistance when monotherapy is used.

Some antivirals are nucleoside or nucleotide analogs that are phosphorylated and incorporated into viral DNA or RNA. They function as chain terminators or introduce faulty bases. Since these analogs may also affect host polymerases, toxicity and selectivity are recurrent themes and often appear in pharmacology questions.

Vaccines and Viral Immunity

You will often be asked to analyze vaccine types and their risk profiles. Although immunology is covered elsewhere, a basic viral perspective is essential.

There are several major types of viral vaccines. Live attenuated vaccines use weakened forms of the virus that replicate to a limited degree and induce strong, often lifelong immunity with cellular and humoral responses. Inactivated vaccines use killed virus and primarily elicit humoral immunity. Subunit or recombinant vaccines contain specific viral proteins, often envelope glycoproteins. Newer platforms include viral vector and nucleic acid vaccines that deliver genes encoding viral antigens.

The choice of vaccine type reflects safety, immunogenicity, and target population. Live vaccines can be contraindicated in pregnancy and immunocompromised patients. Inactivated and subunit vaccines are safer but may require boosters. These general principles apply across many viral diseases.

Passive immunization with antibodies provides immediate but temporary protection. It is often used after high risk exposure to certain viruses or in patients who cannot mount adequate responses.

Viral Diagnosis in Clinical Practice

USMLE questions frequently test interpretation of laboratory approaches to diagnosing viral infections. The key methods are detection of viral nucleic acid, viral antigens, and host antibody responses, along with visualization or culture.

Molecular tests, especially polymerase chain reaction, detect viral DNA or RNA in clinical samples and are highly sensitive and specific. They are widely used for respiratory viruses, herpesviruses, and blood borne viruses. Quantitative PCR can monitor viral load in chronic infections.

Antigen detection uses immunoassays to identify viral proteins in samples, for example in respiratory secretions or stool. These tests are rapid, but sensitivity varies with viral load and timing.

Serology detects host antibodies, particularly IgM in acute infection and IgG in past or resolved infection. Some questions require you to distinguish primary infection, reactivation, and immunity based on combinations of IgM and IgG over time.

Classical viral culture and cytopathic effect observation are used in specialized settings. Electron microscopy is uncommon clinically but appears in exam stems as a clue, especially when describing the appearance of viral particles.

Understanding the strengths and limitations of each method is critical. Molecular tests detect current infection, while serology may detect current or past exposure. False negatives early in infection and cross reactivity in serologic tests are recurring interpretive issues.

Viral Genetics, Mutation, and Antigenic Variation

Viral genomes, especially RNA genomes, exist under constant mutation and selection. The error prone nature of RNA dependent RNA polymerases and reverse transcriptase produces a swarm of related variants within a single host.

Point mutations that accumulate gradually lead to antigenic drift. This small scale variation can alter antigenic sites enough to reduce effectiveness of existing antibodies and vaccines. Drift is common in many RNA viruses.

Occasionally, larger genome changes occur through recombination or reassortment. Viruses with segmented genomes can exchange entire segments when two strains co infect a cell. This reassortment can create new combinations of surface antigens, a process sometimes called antigenic shift in specific contexts when it results in abrupt changes in antigenicity and epidemiology.

These genetic processes underlie the emergence of novel viral strains, outbreaks, and pandemics. They also explain why vaccine composition or antiviral regimens may need ongoing adjustment. USMLE questions often describe sudden appearance of a new strain or a virus that escapes neutralizing antibodies to test your understanding of these mechanisms.

Summary

Viruses are obligate intracellular parasites that use diverse strategies to reach a common goal, production of mRNA and new virions in host cells. Their structural features, genome type, and replication strategies shape their transmission patterns, pathogenic potential, and responses to drugs and vaccines. By mastering the general principles in this chapter, you will have a conceptual scaffold that makes the detailed study of individual viral families and diseases more logical and easier to remember.